279 related articles for article (PubMed ID: 35958463)
1. The role of PI3K/AKT signaling pathway in gallbladder carcinoma.
Wu Z; Yu X; Zhang S; He Y; Guo W
Am J Transl Res; 2022; 14(7):4426-4442. PubMed ID: 35958463
[TBL] [Abstract][Full Text] [Related]
2. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
3. A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth.
Zhang Y; Liu S; Wang L; Wu Y; Hao J; Wang Z; Lu W; Wang XA; Zhang F; Cao Y; Liang H; Li H; Ye Y; Ma Q; Zhao S; Shu Y; Bao R; Jiang L; Hu Y; Zhou J; Chen L; Liu Y
Cancer Lett; 2016 May; 375(1):179-189. PubMed ID: 26949052
[TBL] [Abstract][Full Text] [Related]
4. STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma.
Hu YP; Wu ZB; Jiang L; Jin YP; Li HF; Zhang YJ; Ma Q; Ye YY; Wang Z; Liu YC; Chen HZ; Liu YB
Int J Biochem Cell Biol; 2018 Apr; 97():16-27. PubMed ID: 29413947
[TBL] [Abstract][Full Text] [Related]
5. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
[TBL] [Abstract][Full Text] [Related]
6. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
7. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non-coding RNA LINC00152 by SP1 contributes to gallbladder cancer cell growth and tumor metastasis via PI3K/AKT pathway.
Cai Q; Wang ZQ; Wang SH; Li C; Zhu ZG; Quan ZW; Zhang WJ
Am J Transl Res; 2016; 8(10):4068-4081. PubMed ID: 27829993
[TBL] [Abstract][Full Text] [Related]
9. Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K/AKT signaling pathway.
Mo RL; Li Z; Zhang P; Sheng MH; Han GC; Sun DQ
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38789637
[TBL] [Abstract][Full Text] [Related]
10. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
11. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
[TBL] [Abstract][Full Text] [Related]
12.
Zhu X; Zhang Y; Bian R; Zhu J; Shi W; Ye Y
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398143
[TBL] [Abstract][Full Text] [Related]
13. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT.
Ye J; Qi L; Liang J; Zong K; Liu W; Li R; Feng R; Zhai W
J Cancer; 2021; 12(12):3548-3557. PubMed ID: 33995632
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
[TBL] [Abstract][Full Text] [Related]
15. Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder Cancer via Inhibition of the PTEN/PI3K/AKT Signaling Pathway.
Xuan L; Zhang J; Ji J; Hu J; Li F
Biol Pharm Bull; 2020; 43(10):1511-1518. PubMed ID: 32999161
[TBL] [Abstract][Full Text] [Related]
16. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.
Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
[TBL] [Abstract][Full Text] [Related]
18. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation.
Zhai T; Zhang X; Hei Z; Jin L; Han C; Ko AT; Yu X; Wang J
Front Pharmacol; 2021; 12():628621. PubMed ID: 33679411
[TBL] [Abstract][Full Text] [Related]
19. Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.
Qian L; Li X; Ye P; Wang G; Dai W; Liu Y; Gao Q; Shen G
Cytotechnology; 2018 Feb; 70(1):83-94. PubMed ID: 29170841
[TBL] [Abstract][Full Text] [Related]
20. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
